MELANOMA OF UNKNOWN PRIMARY: A SINGLE-INSTITUTION EVALUATION OF CLINICAL OUTCOMES

被引：0
|
作者：
Dwabe, S. [1 ,2 ]
In, G. [1 ,2 ]
机构：
[1] Los Angeles Cty Univ, Southern Calif Med Ctr, Los Angeles, CA USA
[2] Keck Hosp USC, Los Angeles, CA USA
来源：
JOURNAL OF INVESTIGATIVE MEDICINE | 2022年 / 70卷 / 01期
关键词：
D O I：
10.1136/jim-2022-WRMC.98
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
99
引用
收藏
页码：162 / 163
页数：2
相关论文
共 50 条
  • [41] Clinical outcomes of gemtuzumab ozogamicin for relapsed acute myeloid leukemia: single-institution experience
    Naoko Hosono
    Miyuki Ookura
    Hiroaki Araie
    Mihoko Morita
    Kazuhiro Itoh
    Yasufumi Matsuda
    Takahiro Yamauchi
    International Journal of Hematology, 2021, 113 : 362 - 369
  • [42] Single-institution experience with primary tumours of the male urethra
    Gillitzer, Rolf
    Hampel, Christian
    Wiesner, Christoph
    Hadaschik, Boris
    Thueroff, Joachim
    BJU INTERNATIONAL, 2008, 101 (08) : 964 - 968
  • [43] Correlation of Tumor Location to Clinical Outcomes in Colorectal Cancer: A Single-institution Retrospective Analysis
    Signorelli, Carlo
    Chilelli, Mario Giovanni
    Sperduti, Isabella
    Giacinti, Silvana
    Amodio, Pietro Maria
    Palmieri, Raffaele Macarone
    Ranalli, Teresa Valentina
    Gomes, Vito Vincenzo
    Rosetto, Maria Elena
    Nelli, Fabrizio
    Ruggeri, Enzo Maria
    ANTICANCER RESEARCH, 2019, 39 (09) : 4917 - 4924
  • [44] Outcomes for clinical T3B prostate cancer: A single-institution experience
    Hsu, C-Y.
    Joniau, S.
    Lerut, E.
    Oyen, R.
    Roskams, T.
    Van Poppet, H.
    EUROPEAN UROLOGY SUPPLEMENTS, 2008, 7 (03) : 102 - 102
  • [45] Impact of Rituximab in the Clinical Outcomes of Hairy Cell Leukemia: A Retrospective Single-Institution Analysis
    Gonter-Aubin, Kristen
    Kerr, Daniel Alan
    Rose, Ashley
    Thanh Lana Nguyen
    Chavez, Julio C.
    Ibarz, Javier Pinilla
    BLOOD, 2019, 134
  • [46] Clinical outcomes following proton therapy for adult craniopharyngioma: a single-institution cohort study
    Rutenberg, Michael S.
    Rotondo, Ronny L.
    Rao, Dinesh
    Holtzman, Adam L.
    Indelicato, Daniel J.
    Huh, Soon
    Morris, Christopher G.
    Mendenhall, William M.
    JOURNAL OF NEURO-ONCOLOGY, 2020, 147 (02) : 387 - 395
  • [47] Clinical characteristics and treatment outcomes of non-V600 E/K BRAF mutant melanoma patients: a single-institution experience
    Comito, Francesca
    Aprile, Marta
    Pagani, Rachele
    Siepe, Giambattista
    Sperandi, Francesca
    Gruppioni, Elisa
    Altimari, Annalisa
    De Biase, Dario
    Melotti, Barbara
    MELANOMA RESEARCH, 2022, 32 (06) : 477 - 484
  • [48] Palliative radiotherapy for Japanese patients with malignant melanoma: a single-institution experience
    Koiwai, Keiichiro
    Sasaki, Shigeru
    Yoshizawa, Eriko
    Ina, Hironobu
    Fukazawa, Ayumu
    Sakai, Katsuya
    Ozawa, Takesumi
    Matsushita, Hirohide
    Kadoya, Masumi
    JAPANESE JOURNAL OF RADIOLOGY, 2016, 34 (02) : 125 - 129
  • [49] Talimogene Laherparepvec (TVEC) for the Treatment of Advanced Melanoma: A Single-Institution Experience
    Matthew C. Perez
    John T. Miura
    Syeda Mahrukh Hussnain Naqvi
    Youngchul Kim
    Amanda Holstein
    Daniel Lee
    Amod A. Sarnaik
    Jonathan S. Zager
    Annals of Surgical Oncology, 2018, 25 : 3960 - 3965
  • [50] A single-institution validation of the AJCC staging system for stage IV melanoma
    Neuman, Heather B.
    Patel, Ami
    Ishill, Nicole
    Hanlon, Christine
    Brady, Mary Sue
    Halpern, Allan C.
    Houghton, Alan
    Coit, Daniel G.
    ANNALS OF SURGICAL ONCOLOGY, 2008, 15 (07) : 2034 - 2041
12345